XAGE · Longevity Health Holdings, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on May 14, 2025; bars on opposite sides are not compared.
The closing range begins at the captured split on May 14, 2025.
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
XAGE
this stock
Longevity Health Holdings, Inc.
|
$685,663 | — | +3701.4% | — | 0.1% |
|
PG
PROCTER & GAMBLE Co
|
$340.76B | +1.5% | +3.3% | 22.2 | 1.1% |
|
UL
Unilever PLC
|
$140.65B | -0.4% | — | — | 0.1% |
|
CL
Colgate Palmolive Co
|
$72.81B | +15.6% | +1.7% | 36.1 | 2.2% |
|
RBGLY
Reckitt Benckiser Group PLC
|
$45.20B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- % held
- 0.9%
- Net QoQ
- 0 sh
- Top holder
- DRW Securities, LLC
Performance
Raw-price comparisons begin at the captured split on May 14, 2025; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XAGE | -21.2% | -18.5% | — | -24.6% | — |
| SPY | +1.6% | +1.9% | +16.6% | +1.9% | +12.2% |
| vs SPY | -22.7% | -20.4% | — | -26.5% | — |